Waitlist Mortality for Second Kidney Transplants

2021 ◽  
pp. CJN.15021121
Author(s):  
Mohammad Kazem Fallahzadeh ◽  
Kelly A. Birdwell
Keyword(s):  
Kidney Transplants ◽  
Waitlist Mortality

1630: Clinical Analysis of Factors Affecting Poor Graft Functions Following Kidney Transplants from Non-Heart Beating Cadaveric Donors

2005 ◽  
Vol 173 (4S) ◽  
pp. 441-441
Author(s):  
Ryoichi Shiroki ◽  
Hitomi Sasaki ◽  
Yuusuke Kubota ◽  
Tohru Higuchi ◽  
Mamoru Kusaka ◽  
...  
Keyword(s):  
Clinical Analysis ◽  
Kidney Transplants ◽  
Factors Affecting ◽  
Heart Beating ◽  
Cadaveric Donors

African Americans’ discussions about living‐donor kidney transplants with family or friends: Who, what, and why not?

2021 ◽  
Author(s):  
Nicole DePasquale ◽  
Matthew J. Ellis ◽  
Debra L. Sudan ◽  
Patti L. Ephraim ◽  
Lisa M. McElroy ◽  
...  
Keyword(s):  
African Americans ◽  
Living Donor ◽  
Kidney Transplants ◽  
Donor Kidney ◽  
Living Donor Kidney

Pediatric Risk to OHT (PRO) Score: Insights from UNOS Waitlist Mortality Findings

2021 ◽  
Vol 40 (4) ◽  
pp. S119-S120
Author(s):  
S. Raymundo ◽  
A. Chaudhary ◽  
J. Alejos ◽  
N. Srivastava
Keyword(s):  
Waitlist Mortality

scholarly journals The Addition of C‐Reactive Protein and von Willebrand Factor to MELD‐Na Improves Prediction of Waitlist Mortality

Hepatology ◽  
2021 ◽  
Author(s):  
Patrick Starlinger ◽  
Joseph C. Ahn ◽  
Aidan Mullan ◽  
Georg P. Gyoeri ◽  
David Pereyra ◽  
...  
Keyword(s):  
Von Willebrand Factor ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Von Willebrand ◽  
Willebrand Factor ◽  
Waitlist Mortality

scholarly journals Direct-Acting Antivirals and Organ Transplantation: Is There Anything We Can’t Do?

2020 ◽  
Vol 222 (Supplement_9) ◽  
pp. S794-S801
Author(s):  
Matthew R Kappus ◽  
Cameron R Wolfe ◽  
Andrew J Muir
Keyword(s):  
Organ Transplantation ◽  
The United States ◽  
Virologic Response ◽  
Hcv Infection ◽  
Solid Organ ◽  
Direct Acting Antiviral ◽  
Transplant Candidates ◽  
Direct Acting ◽  
High Sustained Virologic Response ◽  
Waitlist Mortality

Abstract The opioid epidemic has resulted in an increase in organ donors with hepatitis C virus (HCV) infection in the United States. With the development of direct-acting antiviral regimens that offer high sustained virologic response rates even in the setting of immunosuppression after transplantation, these HCV-viremic organs are now being offered to transplant candidates with or without preexisting HCV infection. Strategies for HCV treatment with HCV-viremic organs have included delayed and preemptive approaches. This review will discuss key studies in the different solid organ transplants, recent reports of adverse events, and ethical and regulatory considerations. The efficacy of current HCV therapies has created this important opportunity to improve survival for patients with end-organ failure through greater access to organ transplantation and decreased waitlist mortality rate.

Never functioning kidney transplants and non-classical hyperacute rejection

1991 ◽  
Vol 32 ◽  
pp. 106
Author(s):  
S. Vaidya ◽  
J.A. Ruth ◽  
N.P. Orchard ◽  
N.E. Schroeder ◽  
R.W. Haneke ◽  
...  
Keyword(s):  
Hyperacute Rejection ◽  
Kidney Transplants ◽  
Functioning Kidney
Sign in / Sign up

Export Citation Format

Share Document